Fresenius Kabi Deutschland GmbH
PolandAll drugs from this manufacturer
-
The medicine is used as a solution containing amino acids, carbohydrates, and electrolytes when other methods of nutrition are insufficient, impossible, or contraindicated.
Dosage form: solution for infusion
Active substance Dosage isoleucine 2.5 g leucine 3.7 g lysine hydrochloride 4.125 g methionine 2.15 g phenylalanine 2.55 g threonine 2.2 g tryptophan 1 g valinum 3.1 g arginine 6 g histidine 1.5 g glycine 5.5 g serine 3.25 g tyrosine 0.2 g taurine 0.5 g alanine 7 g proline 5.6 g hydrated sodium glycerophosphate 4.59 g acetic acid glacial 4.5 g potassium hydroxide 1.981 g hydrochloric acid 1.47 ml anhydrous glucose 200 g sodium chloride 1.169 g calcium chloride dihydrate 0.294 g magnesium chloride hexahydrate 0.61 g zinc chloride 0.00545 g ATC: B05BA01
-
The medicinal product is used for the treatment of chronic lymphocytic leukemia, non-Hodgkin lymphomas, and multiple myeloma.
Dosage form: powder for preparation of concentrate for infusion solution
Active substance Dosage bendamustine hydrochloride 2.5 mg/ml ATC: L01AA09
-
The medicine is used to treat prostate cancer in situations where the disease progresses despite the use of other chemotherapy.
Dosage form: solution for infusion, concentrate
Active substance Dosage cabazitaxel 20 mg/ml ATC: L01CD04
-
The medicinal product is used in the treatment of advanced ovarian cancer and small cell lung cancer.
Dosage form: solution for infusion, concentrate
Active substance Dosage carboplatin 10 mg ATC: L01XA02
-
This medicine is used to relax muscles during various surgical procedures in adults and children over 1 month of age. It is also used in Intensive Care Units and to facilitate endotracheal intubation when a patient requires respiratory support.
Dosage form: solution for injection for infusion
Active substance Dosage cisatracurium 2 mg/ml ATC: M03AC11
-
The medicine is used to relax muscles during various surgical procedures in adults and children over 1 month of age. It is also used in Intensive Care Units and to facilitate endotracheal intubation in patients requiring respiratory support.
Dosage form: solution for injection for infusion
Active substance Dosage cisatracurium 5 mg/ml ATC: M03AC11
-
The medicine is used in adults and children for the treatment of acute leukemias (blood cancer). It helps to induce and maintain remission, which is a period when disease symptoms subside and blood cell counts return to normal.
Dosage form: solution for injection for infusion
Active substance Dosage cytarabine 100 mg/ml ATC: L01BC01
-
It is a protein compound administered intravenously as a component of clinical parenteral or enteral nutrition, usually in combination with vitamins, salts, and trace elements.
Dosage form: solution for infusion, concentrate
Active substance Dosage l-alanyl-l-glutamine 200 mg/ml ATC: B05XB02
-
It is a protein compound used intravenously as a component of clinical nutrition (intravenous or enteral), administered along with vitamins, salts, and trace elements.
Dosage form: solution for infusion, concentrate
Active substance Dosage l-alanyl-l-glutamine 200 mg/ml ATC: B05XB02
-
The medicinal product is used in adults for the treatment of testicular cancer, small cell lung cancer, blood cancer (acute myeloid leukemia), lymphatic system tumors (Hodgkin's and non-Hodgkin's lymphoma), and reproductive system cancer (ovarian cancer and gestational trophoblastic disease). In children and adolescents, it is used for the treatment of acute myeloid leukemia and lymphatic system tumors.
Dosage form: solution for infusion, concentrate
Active substance Dosage etoposide 20 mg/ml ATC: L01CB01
-
The medicine is used to treat non-small cell lung cancer, pancreatic cancer, breast cancer, ovarian cancer, and bladder cancer.
Dosage form: solution for infusion, concentrate
Active substance Dosage gemcitabine 38 mg/ml ATC: L01BC05
-
The medicine is used to treat patients with advanced colorectal cancer (including metastatic cancer). It may also be administered alone if patients with metastatic colorectal cancer experience a recurrence or worsening of the disease after previous treatment with fluorouracil.
Dosage form: solution for infusion, concentrate
Active substance Dosage irinotecan hydrochloride trihydrate 20 mg/ml ATC: L01CE02
-
The medicinal product is used in the treatment of colorectal cancer (stage III colon cancer after tumor removal and colorectal cancer with metastases). It is used in combination with other anticancer drugs.
Dosage form: solution for infusion, concentrate
Active substance Dosage oxaliplatinum 5 mg/ml ATC: L01XA03
-
It is a local anesthetic used in adults and adolescents over 12 years of age to numb a part of the body during surgical procedures.
Dosage form: solution for injection
Active substance Dosage ropivacaine hydrochloride 10 mg/ml ATC: N01BB09
-
The medicine is used to prepare the patient for a bone marrow transplant. It works by destroying bone marrow cells, which enables the transplantation of new stem cells and the production of healthy blood cells by the body.
Dosage form: powder for preparation of concentrate for infusion solution
Active substance Dosage thiotepa 15 mg ATC: L01AC01
-
The medicinal product is used to prepare the patient for a bone marrow transplant. It works by destroying bone marrow cells, which enables the transplantation of new stem cells and the production of healthy blood cells by the body.
Dosage form: powder for preparation of concentrate for infusion solution
Active substance Dosage thiotepa 100 mg ATC: L01AC01
-
This medicine is used to restore blood volume following loss, in situations where the use of other fluids (crystalloids) is insufficient.
Dosage form: solution for infusion
Active substance Dosage poly (o-2-hydroxyethyl) starch (130/0.4) 100 g/l sodium chloride 9 g/l ATC: B05AA07
-
This is an antifungal medicine used to treat serious fungal infections, such as invasive aspergillosis, candidemia, severe infections caused by Scedosporium and Fusarium fungi, as well as to prevent infections in high-risk patients after bone marrow transplantation.
Dosage form: solution for infusion, powder for preparation of
Active substance Dosage voriconazole 200 mg ATC: J02AC03